Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 14 December 2026
- Last conf. stmt
- 30 November 2025
Astrazeneca Intermediate Holdings Limited
- Incorporated
- 30 November 2007 (18 years)
- Industry
- Other business support service activities n.e.c. (82990)
- Owned by
- Accounts type
- Full
- Region
- East of England
- Address
- 1 Francis Crick AvenueCambridge Biomedical CampusCambridgeCB2 0AA
Officers 5 active
Officer details are public data from the Companies House register.
Johnstone, Camilla
Secretary · Appointed 1 May 2025
Director · Appointed 1 May 2025
British
Born December 1977 (48)
Director · Appointed 2 August 2021
American
Born April 1974 (52)
Director · Appointed 20 June 2018
British
Born November 1965
Director · Appointed 31 May 2017
British
Born December 1970 (55)
Officer history (16 former)
1 May 2025
1 May 2025
Resigned Bowden, Matthew Shaun as Secretary
1 May 2025
Appointed Johnstone, Camilla as Secretary
1 May 2025
2 August 2021
2 August 2021
27 February 2019
Resigned Jackson-Turner, Katie Louise as Secretary
27 February 2019
Appointed Bowden, Matthew Shaun as Secretary
20 June 2018
31 December 2017
31 May 2017
31 May 2017
1 December 2015
31 July 2015
Resigned O'Grady, Claire-Marie as Secretary
15 July 2015
Appointed Jackson-Turner, Katie Louise as Secretary
17 November 2014
17 October 2014
22 September 2014
2 December 2013
1 November 2013
1 November 2013
31 October 2013
31 October 2012
31 October 2012
1 June 2012
3 January 2012
Resigned Kenyon, Paul as Director
3 January 2012
16 December 2011
16 December 2011
Appointed O'Grady, Claire-Marie as Secretary
30 November 2007
30 November 2007
30 November 2007
30 November 2007
30 November 2007
Appointed Kenyon, Paul as Director
30 November 2007
30 November 2007
30 November 2007
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. 02723534
Group structure 19 shown
Ownership group derived from the Companies House PSC register
Astrazeneca Intermediate Holdings Limited This company Owns 75–100% of shares
Astrazeneca UK Limited Owns 75–100% of shares
Alderley Park Ventures Limited Has significant influence or control
Astrazeneca Death in Service Trustee Limited Owns 75–100% of shares
Astrazeneca Employee Share Trust Limited Owns 75–100% of shares
Astrazeneca Nominees Limited Owns 75–100% of shares
Astrazeneca Quest Limited Owns 75–100% of shares
Astrazeneca Share Trust Limited Owns 75–100% of shares
Astrazeneca Treasury Limited Owns 75–100% of shares
British Pharma Group Limited Holds 25–50% of voting rights
Evinova Limited Owns 75–100% of shares
Kudos Pharmaceuticals Limited Owns 75–100% of shares
Medimmune U.K. Limited Owns 75–100% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 7 August 2026 | Full accounts | 31 December 2025 | 29 | |
| 12 December 2025 | Confirmation statement with no updates | 30 November 2025 | 3 | |
| 2 June 2025 | Full accounts | 31 December 2024 | 29 | |
| 2 May 2025 | Appointment of a director | 2 | ||
| 1 May 2025 | Appointment of a secretary | 2 |
Some other companies at this address
Other companies in this industry
London
Horsforth
Leeds
Southampton
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →